SPENCER STODDARD: Open Payments
NPI 1417645193 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,953 in 118 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $657 · 2025 $1,953
Food & beverage: $1,953
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 19 | $377 |
| Axsome Therapeutics, Inc. | 21 | $371 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $341 |
| E.R. Squibb & Sons, L.L.C. | 20 | $266 |
| JAZZ PHARMACEUTICALS INC. | 9 | $205 |
| Alkermes, Inc. | 18 | $153 |
| Supernus Pharmaceuticals, Inc. | 2 | $86 |
| Janssen Pharmaceuticals, Inc | 4 | $64 |
| Corium, LLC | 1 | $30 |
| HARMONY BIOSCIENCES LLC | 1 | $17 |
Products named: CAPLYTA, Auvelity, COBENFY, REXULTI, XYWAV, ARISTADA, ABILIFY MAINTENA, Qelbree.
Industry payments across NE — which companies pay providers there.
